FDA to Rule on Merck Keytruda Combo by May

Merck& Co. announced that the U.S. FDA has accepted its application for a new Keytruda-plus-chemotherapy combo and granted the drugmaker priority review.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news